In_Vitro_Diagnostics_Market Global Briefing_2018

In Vitro Diagnostics
Market Global Briefing 2018
Including: Molecular Diagnostics, Point-of-Care Diagnostics, Immunochemistry, Microbiology, Hematology
and Immunohematology
Covering: Siemens Healthineers, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Sysmex
Corporation
Feb 2018

Reasons to Purchase
• Get up to date information available on the market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic (2013-17) and
forecast (2017-21) data and understand the drivers and restraints on the
market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
Scope
Markets Covered: Point-of-Care Diagnostics; Immunochemistry; Clinical Chemistry;
Molecular Diagnostics; Microbiology; Hemostasis; Hematology;
Immunohematology
Companies Mentioned: Siemens Healthineers, Abbott Laboratories Inc., Thermo
Fisher Scientific Inc., Sysmex Corporation
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK,
USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South
America, Middle East And Africa
Time series: Five years historic (2013-17) and forecast (2017-21).
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub
segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced
using end notes.

In-Vitro Diagnostics Market
Characteristics
In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and
also monitor a person’s state of health and therapeutic procedures by examining
specimens derived from the human body such as tissue, blood, stools, urine and
the other body fluids. Significant technologies incorporated in in-vitro diagnostics
are polymerase chain reaction, microarray techniques, sequencing technology and
mass spectrometry, which are used for test sample preparation. In-vitro diagnostic
medical devices include reagents, reagent products, control materials, calibration
materials, kits, instruments, apparatus, systems, equipment, pregnancy tests, urine
test strips, blood sugar monitoring systems for diabetics and receptacles for
medical specimens.
The segments that are covered include –
Point-of-Care Diagnostics –
Immunochemistry –
Clinical Chemistry –
Molecular Diagnostics –
Microbiology; Hemostasis –
Hematology; Immunohematology –
In this report market value is defined as the revenues organizations earn by selling
their goods and services within the specified market, based on the price at which
they sell. Only goods and services traded between entities are included.
The revenues for a specified geography are consumption values – that is, they are
revenues generated by organizations in the specified geography within the
specified market, irrespective of where they are produced.

In-Vitro Diagnostics Market
Historic Growth
The global in-vitro diagnostics market grew from $X billion in 2013 to $X billion in
2017 at a compound annual growth rate (CAGR) of X%.
The chart and table below shows the year-on-year growth of the global in-vitro
diagnostics market during 2013 – 2017.
Drivers of the Market:
Restraints on the Market:

In-Vitro Diagnostics Market
Forecast Growth
The global in-vitro diagnostics market grew from $X billion in 2017 to $X billion in
2021 at a compound annual growth rate (CAGR) of X%.
The chart and table below shows the year-on-year growth of the global in-vitro
diagnostics market during 2017 - 2021.
Drivers of the Market:
Restraints on the Market:

In-Vitro Diagnostics Market
Segmentation
The chart and table below shows the split of the in-vitro diagnostics market in 2017.
The total market value for in-vitro diagnostics was $X billion in 2017. The markets
that are covered include Point-of-Care Diagnostics; Immunochemistry; Clinical
Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology;
Immunohematology.
Point-of-Care Diagnostics was the x largest segment in the in-vitro diagnostics
market with X% share of the market. The market value for the point-of-care
diagnostics was $x billion in 2017.
Immunochemistry made up around X% share of the market. The market value for
the immunochemistry was $x billion in 2017.

In-Vitro Diagnostics Market
Regional And Country Analysis
The Asia Pacific was the largest region in the in-vitro diagnostics market in 2017, invitro
diagnostics for $X billion or X% market share.
North America was the x largest region in-vitro diagnostics for $X billion or X%
market share.
Western Europe was the x largest region in-vitro diagnostics for $X billion or X%
market share.

In-Vitro Diagnostics Market
Competitive Landscape
The leading competitors in the global in-vitro diagnostics market are Siemens
Healthineers, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Sysmex
Corporation.
The chart and table below displays the percentage market share of the top players
in the in-vitro diagnostics market industry.
Company Profile
Siemens Healthineers
Overview
Products and Services
Strategy
Financial Performance

Abbott Laboratories Inc.
Overview
Products and Services
Strategy
Financial Performance
Thermo Fisher Scientific Inc.
Overview
Products and Services
Strategy
Financial Performance
Sysmex Corporation
Overview
Products and Services
Strategy
Financial Performance